Please assess the completion status of the following clinical trial:

Trial Title: High Resolution MRI Study for Prostate Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Age over 18 years~* Patients diagnosed with clinically localized prostate cancer~* Low or Low-intermediate Risk Prostate cancer1 defined as:~* Pre-operative prostate specific antigen (PSA) ≤ 20.0 ng/ml~* Clinical stage cT1 or cT2~* Gleason score 3+3 or 3+4~* Patients choosing AS or already on AS as primary management strategy~* No previous treatment for prostate cancer with radiotherapy, chemotherapy, or hormonal therapy~* No contraindications for gadolinium enhanced MRI~Exclusion Criteria:~* No exclusion criteria

- Gender: MALE
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Paired imaging (Type: OTHER): Single arm, paired imaging of high resolution MRI (hrMRI) and stand MRI (sMRI)

Based on this trial design, predict the completion outcome and termination type (if applicable).